ダウンロード数: 417
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s12328-013-0387-9.pdf | 379.17 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Minami, Naoki | en |
dc.contributor.author | Nakase, Hiroshi | en |
dc.contributor.author | Yoshino, Takuya | en |
dc.contributor.author | Yamada, Satoshi | en |
dc.contributor.author | Toyonaga, Takahiko | en |
dc.contributor.author | Honzawa, Yusuke | en |
dc.contributor.author | Matsuura, Minoru | en |
dc.contributor.author | Chiba, Tsutomu | en |
dc.contributor.alternative | 南, 尚希 | ja |
dc.contributor.alternative | 仲瀬, 裕志 | ja |
dc.date.accessioned | 2014-10-02T05:14:30Z | - |
dc.date.available | 2014-10-02T05:14:30Z | - |
dc.date.issued | 2013-06 | - |
dc.identifier.issn | 1865-7257 | - |
dc.identifier.uri | http://hdl.handle.net/2433/190412 | - |
dc.description.abstract | Takayasu arteritis (TA) and inflammatory bowel disease (IBD) are chronic inflammatory disorders. The mechanisms underlying these diseases are not precisely known, but tumor necrosis factor alpha (TNF-α) is considered to have an important role in the pathophysiology of both TA and IBD. Simultaneous occurrence of both TA and IBD is rare. Our first case was a 42-year-old woman with TA and inflammatory bowel disease unclassified. The patient was refractory to treatment with an immunomodulator, and infliximab (IFX) was started. After starting IFX, clinical remission was achieved and maintained for 2 years. The second case was a 34-year-old woman with TA accompanied by Crohn’s disease. Because her abdominal symptoms relapsed despite treatment with an immunomodulator, IFX was started. Both diseases were well controlled for 2 years by scheduled maintenance therapy with IFX. Relapse of the TA required increased doses of IFX at shorter intervals, which relieved her symptoms. Overall, we identified nine cases for which IFX was effective, including our 2 cases. They may demonstrate the efficacy of IFX for IBD with TA and emphasize the role of TNF-α in the pathophysiology. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Springer Japan | en |
dc.rights | The final publication is available at Springer via http://dx.doi.org/10.1007/s12328-013-0387-9 | en |
dc.rights | This is not the published version. Please cite only the published version. | en |
dc.rights | この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。 | ja |
dc.subject | Takayasu arteritis | en |
dc.subject | Inflammatory bowel disease | en |
dc.subject | Tumor necrosis factor alpha | en |
dc.subject | Infliximab | en |
dc.title | Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Clinical Journal of Gastroenterology | en |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 226 | - |
dc.identifier.epage | 230 | - |
dc.relation.doi | 10.1007/s12328-013-0387-9 | - |
dc.textversion | author | - |
dc.identifier.pmid | 26181600 | - |
dcterms.accessRights | open access | - |
出現コレクション: | 学術雑誌掲載論文等 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。